Financials Nath Bio-Genes (India) Limited Bombay S.E.

Equities

NATHBIOGEN

INE448G01010

Fishing & Farming

Market Closed - Bombay S.E. 06:21:09 2024-04-26 am EDT 5-day change 1st Jan Change
207.2 INR +3.83% Intraday chart for Nath Bio-Genes (India) Limited +8.45% -0.07%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 7,813 8,758 2,571 5,705 4,055 2,684
Enterprise Value (EV) 1 7,692 9,126 3,053 6,379 4,942 3,356
P/E ratio 23.1 x 22.8 x 5.09 x 10.2 x -6.02 x 7.67 x
Yield - - - 0.67% 0.94% 1.42%
Capitalization / Revenue 4.08 x 3.79 x 0.92 x 1.85 x 1.46 x 0.89 x
EV / Revenue 4.01 x 3.95 x 1.09 x 2.07 x 1.78 x 1.11 x
EV / EBITDA 18.8 x 21 x 5.57 x 9.5 x 13.1 x 6.89 x
EV / FCF -11.4 x -14.5 x -9.14 x -15.7 x 7.09 x 25.5 x
FCF Yield -8.74% -6.9% -10.9% -6.35% 14.1% 3.92%
Price to Book 1.66 x 1.73 x 0.46 x 0.93 x 0.75 x 0.47 x
Nbr of stocks (in thousands) 19,004 19,004 19,004 19,004 19,004 19,004
Reference price 2 411.1 460.8 135.3 300.2 213.4 141.2
Announcement Date 8/10/18 7/19/19 7/2/20 8/5/21 6/7/22 6/18/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 1,917 2,309 2,799 3,076 2,784 3,014
EBITDA 1 408.3 434.3 548.2 671.5 376.9 487
EBIT 1 398.8 419.9 533.7 643.4 346.2 457.3
Operating Margin 20.81% 18.18% 19.07% 20.92% 12.44% 15.18%
Earnings before Tax (EBT) 1 300.5 388.7 485.1 567.5 -633.9 361.6
Net income 1 294.2 384.3 504.8 556.6 -673.4 350.1
Net margin 15.35% 16.64% 18.04% 18.1% -24.19% 11.62%
EPS 2 17.83 20.22 26.56 29.29 -35.43 18.42
Free Cash Flow 1 -672.5 -630.1 -334.2 -405.2 697.5 131.5
FCF margin -35.09% -27.29% -11.94% -13.17% 25.06% 4.36%
FCF Conversion (EBITDA) - - - - 185.05% 27%
FCF Conversion (Net income) - - - - - 37.56%
Dividend per Share - - - 2.000 2.000 2.000
Announcement Date 8/10/18 7/19/19 7/2/20 8/5/21 6/7/22 6/18/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 368 482 674 888 672
Net Cash position 1 121 - - - - -
Leverage (Debt/EBITDA) - 0.8465 x 0.8787 x 1.003 x 2.356 x 1.38 x
Free Cash Flow 1 -672 -630 -334 -405 697 132
ROE (net income / shareholders' equity) 7.62% 7.87% 9.48% 9.51% -11.7% 6.28%
ROA (Net income/ Total Assets) 4.86% 4.31% 4.85% 5.29% 2.83% 3.73%
Assets 1 6,057 8,914 10,414 10,516 -23,832 9,384
Book Value Per Share 2 247.0 267.0 293.0 323.0 285.0 302.0
Cash Flow per Share 2 23.50 11.20 11.60 15.40 2.190 20.00
Capex 1 8.59 223 42.4 115 210 28.8
Capex / Sales 0.45% 9.65% 1.51% 3.75% 7.55% 0.96%
Announcement Date 8/10/18 7/19/19 7/2/20 8/5/21 6/7/22 6/18/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NATHBIOGEN Stock
  4. NATHBIOGEN Stock
  5. Financials Nath Bio-Genes (India) Limited